Provided by Tiger Trade Technology Pte. Ltd.

Biogen

170.94
-1.1650-0.68%
Volume:1.21M
Turnover:206.07M
Market Cap:25.08B
PE:15.58
High:173.00
Open:171.59
Low:168.56
Close:172.10
52wk High:185.17
52wk Low:110.04
Shares:146.70M
Float Shares:146.23M
Volume Ratio:0.90
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):10.97
EPS(LYR):11.21
ROE:9.31%
ROA:5.75%
PB:1.38
PE(LYR):15.25

Loading ...

BMO Capital Adjusts Price Target on Biogen to $165 From $150, Maintains Market Perform Rating

MT Newswires Live
·
Yesterday

U.S. RESEARCH ROUNDUP-Autozone, Coursera, Lennar

Reuters
·
Yesterday

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST on 2025-12-16

Reuters
·
Dec 17

Ratings Weekly|Amazon, Roku, Five Below, Ulta Beauty, General Motors, Rivian and More to Watch

Tiger Newspress
·
Dec 14

Walmart was too late for a Nasdaq-100 spot - but these 6 stocks made the cut

Dow Jones
·
Dec 14

Nasdaq Says Biogen, CDW Corporation, Globalfoundries, Lululemon Athletica, On Semiconductor, Trade Desk Will Be Removed From Nasdaq 100 Index

Reuters
·
Dec 13

Seagate, Western Digital And Other Four Companies Will Be Added To Nasdaq 100 Index, While Lululemon, ON Semi, Trade Desk And Other Three Companies Will Be Removed

THOMSON REUTERS
·
Dec 13

Morgan Stanley Adjusts Biogen Price Target to $156 From $149, Maintains Equalweight Rating

MT Newswires Live
·
Dec 12

Biogen Shares Down 3.6% After HSBC Cuts to Reduce From Hold

THOMSON REUTERS
·
Dec 10

This Biogen Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday

Benzinga
·
Dec 10

Biogen Cut to Reduce From Hold by HSBC

Dow Jones
·
Dec 10

Biogen Inc. : Wells Fargo Raises Target Price to $190 From $155

THOMSON REUTERS
·
Dec 10

HSBC Downgrades Biogen to Reduce From Hold, Adjusts Price Target to $143 From $144

MT Newswires Live
·
Dec 10

U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer

Reuters
·
Dec 10

Amgen Inc : HSBC Raises Target Price to $425 From $381

THOMSON REUTERS
·
Dec 10

Biogen Receives Health Canada Authorization for Zurzuvae™ (Zuranolone), the First and Only Treatment Indicated for Adults With Postpartum Depression in Canada

THOMSON REUTERS
·
Dec 09

Biogen (BIIB): Assessing Valuation After Promising New Zorevunersen Data in Dravet Syndrome

Simply Wall St.
·
Dec 09

BRIEF-Biogen And Stoke Therapeutics Present Data That Further Support The Disease-Modifying Potential Of Zorevunersen

Reuters
·
Dec 05

Biogen Unveils Promising Clinical Data for Zorevunersen in Dravet Syndrome Treatment

Reuters
·
Dec 05

Stoke Therapeutics and Biogen Present Data That Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting

THOMSON REUTERS
·
Dec 05